Search - tctmd.com

Displaying 821 - 831 of 831

Sort: Relevancy | Date

News Conference News

PARTNER: TAVI Cost Effective Compared With Standard Care

Jason Kahn

April 03, 2011

News Industry News

Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11

March 28, 2011

News Industry News

Advanced Cardiac Therapeutics Initiates First-In-Man CE Mark Clinical Trial to Study Innovative Catheter System for the Treatment of Atrial Arrhythmias

March 17, 2011

News Industry News

Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension

February 22, 2011

News Industry News

Boston Scientific Announces First Use of Blazer® Open-Irrigated Catheter in U.S.

January 26, 2011

News Industry News

St. Jude Medical Announces Launch of the ViewMate Z Intracardiac Ultrasound System and ViewFlex Plus ICE Catheter

January 12, 2011

BIO

Byron K. Lee, MD

Video

» Interview

"Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Results of the VALOR Trial"

May 4, 2022

Video

» Interview

ACC 2022: VALOR-HCM - Mavacamten As An Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

April 3, 2022

Video

Concomitant AF Ablation-LAA Closure- Tilting the Scale Towards Open Surgery- - N. Doll

January 9, 2020

Advertisement

PARTNER: TAVI Cost Effective Compared With Standard Care

Medtronic to Unveil Pivotal U.S. Data on Resolute® Drug-Eluting Stent at ACC.11

Advanced Cardiac Therapeutics Initiates First-In-Man CE Mark Clinical Trial to Study Innovative Catheter System for the Treatment of Atrial Arrhythmias

Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension

Boston Scientific Announces First Use of Blazer® Open-Irrigated Catheter in U.S.

St. Jude Medical Announces Launch of the ViewMate Z Intracardiac Ultrasound System and ViewFlex Plus ICE Catheter

Byron K. Lee, MD

"Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Results of the VALOR Trial"

ACC 2022: VALOR-HCM - Mavacamten As An Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy

Concomitant AF Ablation-LAA Closure- Tilting the Scale Towards Open Surgery- - N. Doll

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content